Pages

Saturday, October 17, 2009

FDA OKs Death-Dealing Gardasil Vax For Boys

Merck & Co.’s Gardasil, a vaccine used to prevent cervical cancer in women, won U.S. regulatory approval for preventing genital warts in boys.

The U.S. Food and Drug Administration cleared the vaccine for use in males ages 9 to 26, Merck said today in a statement.

Approval in boys could add as much as $200 million and $300 million in annual sales, said Leerink Swann & Co. analyst Seamus Fernandez in a research report last month. Gardasil generated revenue of $1.4 billion last year.

Read more...

No comments:

Post a Comment

Thanks for your comment it is much appreciated.